Liberals think they smell more than a little H-Y-P-O-C-R-I-S-Y.

FORBES: In Defense of Arizona's Medicaid Rationing

That's how I first got to know H-P.

WSJ: H-P CEO Meg Whitman Defends Company in Age of Tablets

Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.

FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy

Looking at my statistics though it looks like people only want to read about the S and P down- grade of Treasury securities, so I thought I would share my personal experience with the fall-out.

FORBES: S and P Downgrade - Case Study